alexa Meige′s Syndrome With Parkinson′s Disease: A Rare Case Report | 72832
ISSN: 2165-7920

Journal of Clinical Case Reports
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

5th European Conference on Clinical and Medical Case Reports

Lihuan Lan
Sun Yat-Sen University, China
Posters & Accepted Abstracts: J Clin Case Rep
DOI: 10.4172/2165-7920-C1-012
Abstract
Meige’s syndrome was first introduced in 1910 by Henry Meige, which is characterized by blepharospasm and oromandibular dystonia. A 53-year-old woman reported that she had a 4 years history of PD. The PD began with the resting tremor of the right upper extremity and progressed to bradykinesia. In 2016-10-24, she admitted to our department and initiated to take Levodopa and Benserazide Hydrochloride, Benzhexol Hydrochloride and Pramipexole. With the treatment, the limb tremor and bradykinesia were improved. However, she noted an involuntary movement of tongue and a constriction at the base of the tongue in 2017-01. She denied blepharospasm and any other physical complaints and had no family history of PD or Meige’s syndrome. On physical examination, the main signs were barylalia, involuntary movement of tongue and lips, and resting tremor of the four limbs of the body. Magnetic resonance imaging of head showed that slight increase linear signal with the symmetry of bilateral basal ganglia on T1WI, T2WI and T2-FLAIR, the lesion were well defined and enhanced scan suggested no enhancement. Magnetic resonance angiography did not show abnormal blood vessel. Because Levodopa may result in aggravating patient’s condition, we reduced the Levodopa and Benserazide Hydrochloride dosage, the Pramipexole dosage was advanced, the dosage of Benzhexol Hydrochloride was not changed. Meanwhile, we increase Clonazepam, Tiapride Hydrochloride and Baclofen. The patient had no thrillingness or bradykinesia but had a slight involuntary movement of tongue after 2 days later and maintained 1 week.
image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
Leave Your Message 24x7